2023 annual financial data
CytoMed Therapeutics 2023 Net margin
Direct answer
Net margin was -813.99%.
Operating income was -1,579,150.5 SGD and net income was -4,144,214 SGD.
Operating cash flow was -3,540,867 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 509,125 SGD
- Operating income
- -1,579,150.5 SGD
- Net income
- -4,144,214 SGD
- Operating cash flow
- -3,540,867 SGD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all CytoMed Therapeutics financial years